Eyedea

Xi'an Pulle Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, and production of ophthalmic medical devices. With intraocular lens products for cataract treatment as its core, the company actively explores the field of ophthalmology and is committed to contributing to human visual health. Intraocular lens implantation is the only effective method for treating cataracts and is also the most successful surgery worldwide. Currently, in the Chinese market, foldable intraocular lenses are monopolized by international giants, with a very limited share of domestically produced products. The company is led by world-class academicians and senior experts from China and abroad, forming a research and development team composed of multidisciplinary experts in materials, optics, mechanics, bioengineering, clinical fields, and more.